These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25653235)

  • 1. Activation of PAX3-MET pathways due to miR-206 loss promotes gastric cancer metastasis.
    Zhang L; Xia L; Zhao L; Chen Z; Shang X; Xin J; Liu M; Guo X; Wu K; Pan Y; Fan D
    Carcinogenesis; 2015 Mar; 36(3):390-9. PubMed ID: 25653235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of MicroRNA-489-3p promotes osteosarcoma metastasis by activating PAX3-MET pathway.
    Liu Q; Yang G; Qian Y
    Mol Carcinog; 2017 Apr; 56(4):1312-1321. PubMed ID: 27859625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-144 inhibits the metastasis of gastric cancer by targeting MET expression.
    Liu J; Xue H; Zhang J; Suo T; Xiang Y; Zhang W; Ma J; Cai D; Gu X
    J Exp Clin Cancer Res; 2015 Apr; 34(1):35. PubMed ID: 25927670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by directly targeting MMP14 and Snail.
    Zuo QF; Cao LY; Yu T; Gong L; Wang LN; Zhao YL; Xiao B; Zou QM
    Cell Death Dis; 2015 Nov; 6(11):e2000. PubMed ID: 26610210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia downregulated miR-4521 suppresses gastric carcinoma progression through regulation of IGF2 and FOXM1.
    Xing S; Tian Z; Zheng W; Yang W; Du N; Gu Y; Yin J; Liu H; Jia X; Huang D; Liu W; Deng M
    Mol Cancer; 2021 Jan; 20(1):9. PubMed ID: 33407516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2.
    Wang L; Lin L; Chen X; Sun L; Liao Y; Huang N; Liao W
    Oncotarget; 2015 May; 6(13):11492-506. PubMed ID: 25895023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer.
    Zheng B; Liang L; Wang C; Huang S; Cao X; Zha R; Liu L; Jia D; Tian Q; Wu J; Ye Y; Wang Q; Long Z; Zhou Y; Du C; He X; Shi Y
    Clin Cancer Res; 2011 Dec; 17(24):7574-83. PubMed ID: 21994419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor.
    Zhao X; Dou W; He L; Liang S; Tie J; Liu C; Li T; Lu Y; Mo P; Shi Y; Wu K; Nie Y; Fan D
    Oncogene; 2013 Mar; 32(11):1363-72. PubMed ID: 22614005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-141 inhibits tumor growth and metastasis in gastric cancer by directly targeting transcriptional co-activator with PDZ-binding motif, TAZ.
    Zuo QF; Zhang R; Li BS; Zhao YL; Zhuang Y; Yu T; Gong L; Li S; Xiao B; Zou QM
    Cell Death Dis; 2015 Jan; 6(1):e1623. PubMed ID: 25633292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5.
    Qiao F; Gong P; Song Y; Shen X; Su X; Li Y; Wu H; Zhao Z; Fan H
    Cell Physiol Biochem; 2018; 46(6):2215-2231. PubMed ID: 29734189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-206 Reduces Osteosarcoma Cell Malignancy
    Zhan FB; Zhang XW; Feng SL; Cheng J; Zhang Y; Li B; Xie LZ; Deng QR
    Yonsei Med J; 2019 Feb; 60(2):163-173. PubMed ID: 30666838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-135a promotes gastric cancer progression and resistance to oxaliplatin.
    Yan LH; Chen ZN; Li-Li ; Chen J; Wei WE; Mo XW; Qin YZ; Lin Y; Chen JS
    Oncotarget; 2016 Oct; 7(43):70699-70714. PubMed ID: 27683111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA‑34a attenuates the proliferation, invasion and metastasis of gastric cancer cells via downregulation of MET.
    Wei B; Huang QY; Huang SR; Mai W; Zhong XG
    Mol Med Rep; 2015 Oct; 12(4):5255-61. PubMed ID: 26238271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-589 promotes gastric cancer aggressiveness by a LIFR-PI3K/AKT-c-Jun regulatory feedback loop.
    Zhang F; Li K; Pan M; Li W; Wu J; Li M; Zhao L; Wang H
    J Exp Clin Cancer Res; 2018 Jul; 37(1):152. PubMed ID: 30012200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-26a/HOXC9 Dysregulation Promotes Metastasis and Stem Cell-Like Phenotype of Gastric Cancer.
    Peng X; Kang Q; Wan R; Wang Z
    Cell Physiol Biochem; 2018; 49(4):1659-1676. PubMed ID: 30205370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-940 promotes tumor cell invasion and metastasis by downregulating ZNF24 in gastric cancer.
    Liu X; Ge X; Zhang Z; Zhang X; Chang J; Wu Z; Tang W; Gan L; Sun M; Li J
    Oncotarget; 2015 Sep; 6(28):25418-28. PubMed ID: 26317898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers.
    Zheng B; Liang L; Huang S; Zha R; Liu L; Jia D; Tian Q; Wang Q; Wang C; Long Z; Zhou Y; Cao X; Du C; Shi Y; He X
    Oncogene; 2012 Oct; 31(42):4509-16. PubMed ID: 22179828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling.
    Huang N; Wu Z; Lin L; Zhou M; Wang L; Ma H; Xia J; Bin J; Liao Y; Liao W
    Oncotarget; 2015 Jun; 6(17):15222-34. PubMed ID: 25945841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-206: Effective Inhibition of Gastric Cancer Progression through the c-Met Pathway.
    Zheng Z; Yan D; Chen X; Huang H; Chen K; Li G; Zhou L; Zheng D; Tu L; Dong XD
    PLoS One; 2015; 10(7):e0128751. PubMed ID: 26186594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis.
    Li X; Jiang M; Chen D; Xu B; Wang R; Chu Y; Wang W; Zhou L; Lei Z; Nie Y; Fan D; Shang Y; Wu K; Liang J
    J Exp Clin Cancer Res; 2018 Mar; 37(1):71. PubMed ID: 29587866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.